Back to search

Article

Metformin may improve the outcome of patients with breast cancer and type 2 diabetes mellitus through the effect of tumor immune microenvironment.

2023-08-23

Abstract excerpt

<title>Abstract</title> <p>The antidiabetic drug metformin has antitumor effects. We examined the outcome of 177 patients with type 2 diabetes mellitus who received surgery for breast cancer. Among them, 49 patients were treated with metformin. In those patients, recurrence in distant organs was less frequent and postoperative disease-free survival tended to be better than in those without metformin intake. In pa...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c2944b97-aaf6-5dc8-bd59-bd1d6fcf83a8
DOI
10.21203/rs.3.rs-3271592/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Metformin may improve the outcome of patients with breast cancer and type 2 diabetes mellitus through the effect of tumor immune microenvironment.DOI 10.21203/rs.3.rs-3271592/v1
Select a neighboring publication to make it the new centre.